Screener
Harmony Biosciences Holdings, Inc. HRMY Sales Based Trademark And Tiered Royalties — Accrued Royalties Current
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Harmony Biosciences Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccruedRoyaltiesCurrent.
The source filing: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 8:16 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-056720
| Line item | As of / March 31, 2026 | As of / December 31, 2025 |
|---|---|---|
| Royalties | $41,906 | $65,819 |
| Rebates and other sales deductions | 77,448 | 76,304 |
| Interest | 1,910 | 2,151 |
| Sales and marketing | 4,915 | 3,153 |
| Research and development | 10,246 | 12,193 |
| Legal and professional fees | 11,797 | 29,999 |
| Other expenses | 1,885 | 1,420 |
| $150,107 | $191,039 |
Item 1. Financial Statements
FAQ
- What is Harmony Biosciences Holdings, Inc.'s sales based trademark and tiered royalties — accrued royalties current?
- Harmony Biosciences Holdings, Inc. (HRMY) reported sales based trademark and tiered royalties — accrued royalties current of $41.91M in Q1 2026.
- How has Harmony Biosciences Holdings, Inc.'s sales based trademark and tiered royalties — accrued royalties current changed year-over-year?
- Harmony Biosciences Holdings, Inc.'s sales based trademark and tiered royalties — accrued royalties current increased by 41.8% year-over-year, from $29.56M to $41.91M.
- What does sales based trademark and tiered royalties — accrued royalties current mean?
- This metric reflects the current liability for royalty payments owed to third parties based on the sales performance of specific trademarked products. It represents the obligation to compensate licensors or partners for the use of intellectual property within the current reporting period. Tracking this liability provides insight into the company's short-term cash flow obligations and the ongoing cost structure associated with its licensed pharmaceutical portfolio.
Ask your AI about Harmony Biosciences Holdings, Inc.'s sales based trademark and tiered royalties — accrued royalties current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude